busulfan has been researched along with Adenocarcinoma Of Kidney in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a Phase I and pharmacokinetic study of once-daily, intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and matched sibling donor allogeneic stem cell transplantation for treatment of metastatic renal cell carcinoma." | 2.72 | Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma. ( Alexander, W; Bachier, C; LeMaistre, C; Pollack, M; Ririe, D; Shaughnessy, P; Splichal, J; Tran, H, 2006) |
| "Therapy of advanced renal cell carcinoma remains difficult." | 1.30 | [Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression]. ( Gross, AJ; Hemmerlein, B; Kallerhoff, M; Kugler, A; Ringert, RH; Seseke, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omori, S | 1 |
| Fujioka, T | 1 |
| Ono, Y | 1 |
| Numaoka, H | 1 |
| Ishida, Y | 1 |
| Mertins, SD | 1 |
| Myers, TG | 1 |
| Holbeck, SL | 1 |
| Medina-Perez, W | 1 |
| Wang, E | 1 |
| Kohlhagen, G | 1 |
| Pommier, Y | 1 |
| Bates, SE | 1 |
| Shaughnessy, P | 1 |
| Alexander, W | 1 |
| Tran, H | 1 |
| Ririe, D | 1 |
| Splichal, J | 1 |
| Pollack, M | 1 |
| Bachier, C | 1 |
| LeMaistre, C | 1 |
| Foa, P | 1 |
| Iurlo, A | 1 |
| Maiolo, A | 1 |
| Kugler, A | 1 |
| Hemmerlein, B | 1 |
| Gross, AJ | 1 |
| Seseke, F | 1 |
| Kallerhoff, M | 1 |
| Ringert, RH | 1 |
1 trial available for busulfan and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Topics: Aged; Area Under Curve; Busulfan; Carcinoma, Renal Cell; Hematopoietic Stem Cell Transplantation; Hu | 2006 |
4 other studies available for busulfan and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; | 2004 |
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cyc | 2004 |
Renal cancer after busulphan treatment for chronic myeloid leukemia: therapeutic implications.
Topics: Busulfan; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL P | 1993 |
[Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression].
Topics: Antineoplastic Agents, Alkylating; Busulfan; Carcinoma, Renal Cell; Cell Survival; Dose-Response Rel | 1998 |